Study Details

Back
Study ID 178-CL-008
Study Title A randomized, double-blind, parallel group, proof of concept study of YM178 in comparison with placebo and tolterodine in patients with symptomatic overactive bladder
Clinicaltrials.gov Identifier 01604928
Compound Name YM178 / mirabegron
Medical Indication or Disease Overactive bladder
Study Sponsor Astellas Pharma Europe B.V.
Collaborator Not Applicable
Study Start Date 05-Apr-2004
Study Completion Date 25-Jan-2005
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS